AVR-RD-01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVR-RD-01, covering 2024-01-05 to 2024-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Open Label, Study Of Efficacy and Safety Of AVR-RD-01 for Treatment-Naive Subjects With Classic Fabry Disease [Phase 1, Phase 2]